UVSSA

Across TCGA pan-cancer cohorts, UVSSA Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated UVSSA data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher UVSSA Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated UVSSA expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ACC, STAD, and LUAD are the cancer types where UVSSA Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.046	0.753	<.001	36	view →
STAD	OS	Median	All	0.173	0.672	<.001	18	view →
LUAD	OS	Median	All	0.266	0.835	<.001	18	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
BLCA	OS	Median	All	0.216	0.686	.037	12	view →
LIHC	OS	Median	All	0.231	0.690	.011	9	view →
UCEC	DFS	Median	II,III,IV	0.924	0.436	.023	8	view →
SKCM	OS	Median	All	0.122	0.344	.008	4	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

UVSSA–ACC (DFS)

Open the ACC breakdown →